Furthermore, the study observed a shift in FOXP1 localization from the nucleus to the cytoplasm with increasing tumor malignancy, suggesting reduced nuclear FOXP1 expression and increased cytoplasmic staining. The gene discussed is FOXP1; the disease is neoplasm.